Kenneth Blum, Ph.D., DHL
Dr. Kenneth Blum, B.Sc (Pharmacy), M.Sc., PhD, DHL- received his PhD in Neuropharmacology from New York Medical College and is a graduate from Columbia University and New Jersey College of Medicine. He trained at the Institute of Behavioral Genetics, Colorado University, Boulder, Colorado. He also received a doctor of humane letters from St Martins University. He has published 542 abstracts, peer –reviewed articles and books (14). He has been the recipient of many grants and awards including a Life-Time Achievement in Addiction Medicine (Holistic Institute on Addiction Studies) and Presidential Award for Scientific Excellence (National Council of Alcohol & Drug Abuse Councilors), Scientific Achievement Award (City of Life Miami) and Best Abstract (2012) Award ASRA (Pain). Currently he serves as EIC Human Pharmacology, Toxicology and Genomic reports and CO EIC for Addiction Genetics, and is on the editorial board of 14 other scientific journals. READ MORE
Goutham Edula, M.S.
Dr. Goutham Edula completed his medical education from Osmania Medical college and has an MS degree in Biomedical Informatics from Singapore. He has worked as Senior Scientist and Senior Research physician in Eli Lilly in Singapore and AstraZeneca Pharmaceuticals in Sweden for 12 years. He is the founder director of several medical research and innovation based companies in US, EU, Singapore and India. He has extensive experience in incorporating healthcare related business and building them into successful global enterprises. He lectures to medical students in Europe, and has published 12 research publications and one book chapter. READ MORE